Page 18 - Akili Interactive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SVP, engagement strategy, CDM Princeton Women are now leaving the workforce at four times the rate of men. What needs to be done to alleviate this?  This stat indicates that women are losing choice. Between the pay gap issue and domestic inequities at home, we have a sad state of affairs. To reverse this trend, we’d need a major cultural reset of expectations for women at home, at work and policies that ensure subsidies for childcare and equal compensation. In the meanwhile, we can all make a difference right now. We can hire women, compensate them equally and provide flexibility for th...

Science’s COVID-19 reporting is supported by the Heising-Simons Foundation. Since she fell ill with COVID-19 around Thanksgiving, Pamela Furr has been waiting for her old self to return. A radio news anchor in Tennessee for more than 10 years, she now sometimes finds herself stuck midsentence grasping for simple words; she is prone to forget events and conversations if she doesn’t write them down. “I’m not the same person that I was before COVID,” she says. “I kind of miss me.” The true prevalence of cognitive problems in COVID-19 survivors is elusive, and the underlying causes ...

Doctors are testing a prescription video game for COVID-19 ‘brain fog’ The game is cleared for use in ADHD Share this story Photo by Dina Rudick/The Boston Globe via Getty Images A research team is testing a prescription video game to see if it can help people who have lingering memory and attention problems after recovering from COVID-19. Many people who survived the disease say that they’re often confused and have difficulty focusing, and research studies show that the symptoms can stick around for months after they recover. Faith Gunning, a neuropsychologist at Weill Cornell Medicin...

Photo by Akili Interactive. Akili Interactive, the maker of the FDA De Novo-authorized digital therapeutic EndeavorRx, will be testing its video game ADHD treatment as a potential treatment for cognitive impairments in COVID-19 survivors. Through collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center, Akili will conduct two separate randomized, controlled clinical studies evaluating EndeavorRx’s ability to target and improve cognitive functioning in COVID-19 survivors who have exhibited a deficit in cognition. EndeavorRx (previous...

Share this article Share this article PUNE, India, March 8, 2021 /PRNewswire/ -- Digital Therapeutics Market is valued at USD 1.99 Billion in 2017 and Projected to reach USD 14.54 Billion by 2027 with a CAGR of 22% over the forecast period. Technological advancement in medical sector and demand in digital healthcare facilities are key driving factors for the growth of Digital Therapeutics Market. : Dario Health, Pear Therapeutics, Omada Health, Click Therapeutics, Akili Interactive, Lark Health, Kaia Health, Cognoa News: Medisafe, digital therapeutics company raises $30M: February 28, 2021; ...